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INVESTIGATION

Impact of Genetic Background on Neonatal
Lethality of Gga2 Gene-Trap Mice
Balraj Doray, Jennifer Govero, and Stuart Kornfeld1
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110

ABSTRACT The functional redundancy of the three mammalian Golgi-localized, g-ear–containing, ADPribosylation factor-binding proteins (GGAs) was addressed in a previous study. Using insertional mutagenesis, we found that Gga1 or Gga3 homozygous knockout mice were for the most part normal, whereas mice
homozygous for two different Gga2 gene-trap alleles exhibited either embryonic or neonatal lethality in the
C57BL/6 background, depending on the source of the vector utilized (Byg vs. Tigm, respectively). We now
show that the Byg strain harbors a disrupted Gga2 allele that is hypomorphic, indicating that the Byg
lethality is attributable to a mechanism independent of GGA2. This is in contrast to the Tigm Gga2 allele,
which is a true knockout and establishes a role for GGA2 during the neonatal period. Placement of the Tigm
Gga2 allele into the C57BL6/Ola129Sv mixed background results in a lower incidence of neonatal lethality,
showing the importance of genetic background in determining the requirement for GGA2 during this
period. The Gga22/2 mice that survive have reduced body weight at birth and this runted phenotype is
maintained through adulthood.

The Golgi-localized, g-ear–containing, Arf-binding proteins (GGAs)
are a family of monomeric clathrin adaptor proteins that function in
receptor trafﬁcking between the trans-Golgi network (TGN) and endosomes (Bonifacino 2004; Braulke and Bonifacino 2009). There are
three homologous GGAs in mammalian species termed GGA1,
GGA2, and GGA3. These proteins have identical domain organizations with an N-terminal VHS (VPS-27, Hrs, and STAM) domain
followed by a GAT (GGA and Tom1) domain, a connecting hinge
segment, and a C-terminal GAE domain that is homologous to the ear
domain of g-adaptin (Braulke and Bonifacino 2009). The VHS and
GAT domains of the three human GGAs are conserved with 60–75%
identity (Boman et al. 2000), but the similarity between each GGA
becomes much less pronounced across the entire molecule within
a given species. However, the individual GGAs display approximately
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90% identity between the human and mouse counterparts (Govero
et al. 2012).
We and others have noted a number of similarities between GGA1
and GGA3 that are not shared by GGA2. For instance, human GGA1
and GGA3, but not GGA2, are phosphorylated in vivo and subject to
autoinhibition mediated by binding of internal acidic cluster-dileucine
motifs present in the hinge to the ligand binding site on the VHS
domain (Doray et al. 2002; McKay and Kahn 2004). In addition, the
GAT domains of human GGA1 and GGA3, but not GGA2, bind
ubiquitin and ubiquitinated proteins (Shiba et al. 2004; Yogosawa
et al. 2006), and GGA1 and GGA3, but not GGA2, are depleted in
the brains of patients with Alzheimer disease (Walker et al. 2012).
Also, GGA2 has a shorter half-life than GGA1 and GGA3 (Hirst et al.
2007). Finally, only GGA2 is detectable in isolated HeLa cell clathrincoated vesicles (CCVs) by either Western blotting or mass spectrometry and is dependent on AP-1 for incorporation into CCVs (Hirst
et al. 2009; Hirst et al. 2012). Taken together, these ﬁndings suggest
that GGA1 and GGA3 may perform more overlapping functions
in vivo than does GGA2, and/or that GGA2 may perform some
unique role not mediated by GGA1 and GGA3.
Consistent with this idea, we previously showed that loss of
either GGA1 or GGA3 is well-tolerated in mice, indicating that the
remaining members are able to compensate for the loss (Govero
et al. 2012). However, gene-trap disruption of the Gga2 gene resulted
in either embryonic lethality with the BayGenomics (Byg) gene-trap
or neonatal lethality with the Texas Institute for Genomic Medicine
(Tigm) gene-trap (Govero et al. 2012). We initially considered
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whether this difference in phenotype was attributable to differences
in genetic backgrounds, because the Byg strain was generated in the
C57BL6/Ola129Sv mixed genetic background, while the Tigm strain
was in the C57BL/6NJ background. However, backcrossing of the
Byg strain into the C57BL/6J background still resulted in embryonic
lethality, leaving the basis for this difference in outcome unclear at
the time and the question of a role for GGA2 in embryonic development unresolved (Govero et al. 2012).
Subsequently, on review of the Western blot data of brain tissue
from wild-type (wt)and heterozygous (het) progeny of the Gga2+/2
crosses corresponding to the Byg strain, we observed that the het mice
frequently expressed GGA2 protein at a level similar to wt, indicating
that the Byg Gga2 gene-trap allele is likely to be a hypomorphic allele.
To verify this, we have generated compound het mice by crossing Byg
and Tigm Gga2+/2 mice in the C57BL/6J and C57BL/6NJ backgrounds, respectively. This has allowed us to unequivocally show that
the embryonic lethality associated with the Byg Gga2 gene-trap allele
is not attributable loss of GGA2 because this allele is clearly hypomorphic. In addition, we introduced the Tigm Gga2 gene-trap allele
into the C57BL6/Ola129Sv mixed genetic background and demonstrated that the severity of the neonatal lethality associated with this
allele is strongly inﬂuenced by the genetic background of the mice in
which the allele occurs. These studies show that the Gga22/2 mice
have a runted phenotype.
MATERIALS AND METHODS
All protocols involving the use of animals were in compliance with the
National Institutes of Health’s Guide for the Care and Use of Laboratory Animals and approved by the Animal Studies Committee in the
Division of Comparative Medicine at Washington University School
of Medicine in St. Louis (Protocol #20130010). Mice were housed in
a barrier facility maintained under standards meeting federal,
state, and local guidelines and under the supervision of licensed
veterinarians.
Generation of Gga knockout mice
The Byg (cell-line ID SYA176) and Tigm (cell-line ID IST10483E10)
Gga2+/2 gene-trap mice in the C57BL/6J and C57BL/6NJ backgrounds, respectively, have been described (Govero et al. 2012).
Primer sequences used for genotyping of mice and distinguishing
between the two mutant Gga2 alleles, PCR conditions, and the sizes
of all PCR products have been presented (Govero et al. 2012). The
screen used in this study to identify the compound hets is illustrated in
Supporting Information, Figure S1.
Harvesting mouse tissues and Western blot analyses
Adult mice were killed by CO2 inhalation whereas newborns were
killed by decapitation. For serum preparation, blood was collected
in a microfuge tube immediately after decapitation of newborns,
allowed to sit at room temperature for 30 min, and centrifuged at
2000·g for 10 min to separate the clotted components. Brain tissue
was removed and cellular extracts were prepared exactly as described
(Govero et al. 2012). All protein samples were diluted to 5 mg/ml
before being boiled in SDS sample buffer for gel loading. Proteins were
resolved by SDS-PAGE, transferred to either nitrocellulose or PVDF
membrane, and probed with the following antibodies: anti-GGA2
(GGA2 E-3; Santa Cruz); anti-GAPDH (Sigma); anti-CI-MPR (Zhu
et al. 2001); anti-SorLA (BD Transduction Laboratories); and antiSortilin (Sigma),.
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Serum IGF-II measurement by ELISA
Serum IGF-II levels of newborn mice were measured using a modiﬁcation of the ELISA procedure that has been described by Mason
et al. (2011). All reactions were performed in 96-well tissue culture
plates. Brieﬂy, puriﬁed monoclonal rat anti-mouse IGF-II antibody
(R&D) was coated on the plate [2.5 mg in a ﬁnal volume of 200 ml
phosphate-buffered saline (PBS) per well] overnight on a shaker at 4.
The next day, the wells were washed three times with wash buffer
(PBS with 0.05% Tween-20), followed by three washes with SuperBlock T20 blocking buffer (Thermo Scientiﬁc).
For serum preparation, 100 ml acid/ethanol reagent (12.5% 2N
HCl, 87.5% ethanol) was added to 15 ml serum sample and incubated at room temperature for 30 min, followed by centrifugation at 10,000·g for 10 min. All the supernatant was removed and
neutralized with 120 ml neutralization buffer (4· PBS containing
0.25% BSA and 500 ng/ml IGF-I). Standards were prepared by
diluting recombinant mouse IGF-II (R&D) in dilution buffer
(PBS with 0.1% Tween-20 and 0.25% BSA). Standards ranged in
concentration from 2000 pg/ml to 125 pg/ml. A blank control (500
ng/ml IGF-I in dilution buffer) was also included for subtraction.
Standard, control, or samples (100 ml/well) were combined with
50 ng (100 ml) biotinylated goat anti-mouse IGF-II antibody
(R&D) and incubated for 3 hr on a shaker at room temperature.
The wells were washed three times with wash buffer, after which
200 ml of a 1:200 dilution of streptavidin-HRP conjugate (R&D) in
dilution buffer was added to each well and incubated for 45 min at
room temperature. The wells were then washed four times with
wash buffer and 200 ml of 3,39,5,59-Tetramethylbenzidine in buffered hydrogen peroxide (Sigma) was added to each well and incubated at room temperature for 30 min to allow the color to
develop. Then, 50 ml of 1 M H2SO4 was added per well to stop
the reaction and produce a yellow color, and the absorbance was
read at 450 nm.
RESULTS
Generation and analysis of Gga22/2
compound heterozygotes
We initially crossed Byg Gga2+/2 mice in the C57BL/6J genetic background with Tigm Gga2+/2 mice in the C57BL/6NJ background using
the mating scheme illustrated in Figure 1A. To facilitate the description of the compound heterozygotes, +/Byg and +/Tigm refer to mice
that have one wild-type (wt) (+) and one Gga2 gene-trap allele (either
the Byg or the Tigm Gga2 gene-trap allele, respectively), whereas Byg/
Tigm are compound hets that harbor both the Byg and Tigm Gga2
gene-trap alleles. Byg/Byg and Tigm/Tigm, however, refer to homozygous mice carrying two copies of either the Byg or the Tigm Gga2
gene-trap alleles, respectively. Although the gene-trap cassette is
inserted into intron 1 of the Gga2 gene in both strains, the position
of insertion was different (Figure S1), as was the nature of the vectors
utilized. Details for genotyping that distinguished between the two
alleles and allowed for identiﬁcation of compound hets (Byg/Tigm)
are provided in Figure S1. As expected if the Byg allele is hypomorphic, all the compound hets that were born were viable and normal in
all respects even though these mice are Gga22/2 at the DNA level. We
next mated the Byg/Tigm compound hets with either Byg Gga2+/2
mice (+/Byg)( Figure 1B) or Tigm Gga2+/2 (+/Tigm) (Figure 1C). The
results of the genotyping and the Western blot data of the progeny
(day 1 pups of a representative litter) from the former mating scheme
are shown in Figure 1D. As controls, wt or Tigm Gga22/2 (Tigm/
Tigm) samples were included. Strikingly, in this litter the two Byg

Figure 1 Generation and immunoblot analysis of Byg/
Tigm compound hets. (A–C) Mating schemes used to
generate compound heterozygous mice harboring both
the Byg and Tigm mutant Gga2 alleles. The Byg strain
was backcrossed for at least eight generations into the
C57BL/6 genetic background before being crossed with
the Tigm strain, also in the C57BL/6 background. (D and E)
Genotyping results and Western blot analysis of brain tissue from day 1 pups of representative litters resulting from
the mating schemes shown in (B and C), respectively.
Twenty-ﬁve mg of protein extract for each sample was
subjected to SDS-PAGE and immunoblot analysis of
GGA1, GGA2, GGA3, AP-1, and GAPDH (5 mg of lysate)
as a control. A non-speciﬁc band. Use of a 4–12%
Bris-Tris gradient gel (E) resulted in better separation of
the GGA2 band from the non-speciﬁc band compared to
a 10% Tris-Glycine gel (D).

Gga2+/2 pups (Figure 1D +/Byg, lanes 7 and 8) had higher brain
expression of GGA2 than the Tigm Gga2+/2 pup (+/Tigm, lane 5)
similar to wt (compare lane 3 with lanes 7 and 8). The two compound
hets (Byg/Tigm, lanes 4 and 6), however, although genetically Gga22/2,
had similar expression as the Tigm Gga2+/2 pup (+/Tigm, lane 5).
We then examined brain extracts from another representative litter
(Figure 1E) representing the mating scheme shown in Figure 1C. The
large number of compound hets in this litter provided a good opportunity to monitor the GGA2 protein level in these mice. Immunoblot
analysis of brain tissue extracts (Figure 1E) showed that the Tigm
Gga22/2 pup in this litter (Tigm/Tigm, lane 2) had no detectable
GGA2, even on long exposure of the blot, whereas the Byg Gga2+/2
pup (+/Byg, lane 6) had the highest expression. Of note, GGA2 was
detected in every compound het (Byg/Tigm, lanes 1, 3, 4, 5, 7, and 8),
although there was substantial variability in the expression level (compare lanes 4 and 5 to 7 and 8.). It has been reported that a gene-trap

inserted in intron 1 of the Prep1 gene gave rise to a hypomorphic
mutation that also resulted in variable expression of the Prep1 protein
and an embryonic lethal penetrance that was dependent on the degree
of leakiness of the gene-trap cassette (Ferretti et al. 2006). GGA1,
GGA3, and AP-1, in contrast, did not display this variability between
the different genotypes. Analysis of brain, heart, and lung tissue
extracts from other litters also showed variation in the expression of
GGA2 among the compound hets and Byg Gga2+/2 (+/Byg) pups
(Figure S2), indicating that the Byg allele must be producing wt message in addition to the chimeric Gga2-bgal transcript. The presence of
this chimeric mRNA in Byg Gga2+/2 mice was demonstrated previously by reverse-transcriptase polymerase chain reaction (RTPCR) (Govero et al. 2012). Long exposure of the GGA2 blots also
revealed that an occasional Tigm Gga22/2 pup expresses very low
levels of GGA2 that could at times be detected (Figure S2, long exposure of brain and lung GGA2) but, for the most part, even if there
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was low level expression, it was below the detection limit (Figure 1E
and Figure 2C long exposure of GGA2). Western blot analysis of
varying amounts of wt brain lysate run alongside a Gga22/2 brain
lysate where some expression was observed, indicating that this low
level expression is in the range of 1–2.5% relative to wt (Figure S3).
Importantly, progeny corresponding to every possible genotype were
obtained from the crosses shown in Figure 1, A–C, with the exception
of Byg Gga22/2 mice (Byg/Byg) (Figure 1B), highlighting the fact that
the embryonic lethality associated with the Byg allele in the homozygous state persists in the C57BL/6NJ background.
These results conﬁrm that the embryonic lethality of the Byg
Gga22/2 mice is not attributable to the absence of GGA2. In view of
this, we decided not to pursue this Byg strain further.
Inﬂuence of genetic background on neonatal lethality of
Tigm Gga22/2 gene-trap mice
We previously presented data showing that the Tigm Gga22/2 phenotype in the C57BL/6NJ background is neonatal lethal, exhibiting more
than 95% mortality rate with one single survivor that lived beyond 3 wk
(Govero et al. 2012). The surviving Gga22/2 mouse was a female that
was 25% smaller than its littermates at 4 wk of age but had a normal
lifespan. Genotyping of an additional 65 offspring from Tigm Gga2+/2
intercrosses that survived beyond 2 wk identiﬁed only one Gga22/2
mouse that had survived up to that point. This surviving mouse was
a male that weighed 50% less than its littermates and had to be killed at
3 wk due to marked cachexia. Histological examination did not reveal
any pathologic changes in the internal organs (not shown), similar to
the situation with the newborn Gga2 knockouts (Govero et al. 2012).
These results conﬁrm our previous ﬁnding that Gga22/2 mice display
a neonatal lethal phenotype in the C57BL/6NJ background.
To analyze the inﬂuence of the genetic background on the
consequence of the loss of GGA2, the Tigm Gga2 allele was introduced into the mixed background by mating Tigm Gga2+/2 females in
the C57BL/6NJ background with a wt male in the C57BL6/Ola129Sv
mixed background. All the resulting N1 Gga2+/2 mice were subsequently mated. Initially, all progeny of the Gga2+/2 crosses were collected soon after birth and genotyped, including pups that died during
or immediately after birth. Figure 2A shows that Gga22/2 mice in the
mixed genetic background are born in near accordance with the
expected Mendelian ratio, as was the case in the C57BL/6NJ background (Govero et al. 2012). Of note, the Gga22/2 mice exhibited
increased mortality compared to wt and hets at this time point, although the difference was not statistically signiﬁcant based on our
sample size. In a separate experiment, 122 offspring were genotyped
by PCR 1 wk after birth, along with the dead pups recovered during
this period (Figure 2B). An additional three mice were recorded as
being born but were missing and presumably cannibalized, so they
could not be genotyped. Of the 25 Gga22/2 offspring that were born
within this group, 14 (56%) died within the ﬁrst week, with almost all
dying within the ﬁrst 48 hr. This is in stark contrast to the mortality
rate of wt and Gga2+/2 mice in the same background (6% and 10%,
respectively). The result is also signiﬁcantly different from the ﬁnding
in the C57BL/6NJ background, where the lethality rate is more than
95% in the Gga22/2 homozygous state (Govero et al. 2012). Of the
surviving Tigm Gga22/2 mice in the C57BL6/Ola129Sv mixed background, none have died beyond the 3-wk period, with the oldest
mouse now 9 months old, and both males and females are fertile.
Because 11 of 25 Tigm Gga22/2 mice in the mixed background
survived beyond 3 wk, it was conceivable that these mice might express more GGA2 than do the Tigm Gga22/2 mice in the C57BL/6NJ
background. However, Western blot analysis of brain tissue extracts
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Figure 2 Inﬂuence of genetic background on severity of neonatal
lethality associated with loss of GGA2. (A and B) The progeny of Tigm
Gga2+/2 crosses in the C57BL6/Ola129Sv mixed genetic background
were genotyped by PCR within 24 hr after birth (A), or after 1 wk (B),
and includes all dead pups that were recovered. The six deaths at birth
of the Gga22/2 mice were not signiﬁcant compared to the two wt
deaths at birth, whereas the 14 deaths () that occurred neonatally
were highly signiﬁcant, as determined by the Fisher exact test (P ,
0.0001). (C) Western blot analysis of brain tissue from representative
day 1 pups resulting from Tigm Gga2+/2 crosses in the mixed genetic
background. Twenty-ﬁve mg of protein extract for each sample was
subjected to SDS-PAGE and immunoblot analysis of GGA2 and
GAPDH (5 mg of lysate) as a control.

prepared from day 1 pups in the mixed background probed for
GGA2 showed no detectable protein in the Gga22/2 mice in most
instances (representative pups shown in Figure 2C), although occasionally the same low-level expression was observed as with the
Tigm Gga22/2 mice in the C57BL/6NJ background. Taken together, these results indicate that the partial rescue of the neonatal
lethality in the mixed background is not due to increased expression of GGA2, but rather it is the genetic background of the mice
that plays an important role in determining viability in the absence
or near-complete loss of GGA2.
One consistent phenotype that was observed with the Gga22/2
mice in the mixed genetic background was that both males and
females were signiﬁcantly smaller than their siblings (Figure 3,
A–C). Because the GGAs are known to be involved in the trafﬁcking
of the cation-independent mannose 6-phosphate receptor (CI-MPR)
(Nielsen et al. 2001; Puertollano et al. 2001; Takatsu et al. 2001; Zhu
et al. 2001), which clears insulin-like growth factor-II (IGF-II) from
blood (Morgan et al. 1987), we considered the possibility that loss of
GGA2 might result in increased levels of the CI-MPR at the plasma
membrane, which, in turn, might lower the blood IGF-II level and
inhibit growth. To investigate this possibility, serum IGF-II levels of
day 1 pups were measured by enzyme- linked immunosorbent assay
(ELISA). The levels were similar in all three genotypes, indicating that
lack of circulating IGF-II is not the cause of the reduced body weight
of Gga22/2 mice (Figure 4A). We also found that the expression level
of the CI-MPR, SorLA, and Sortilin are unaltered in brain tissue of
Gga22/2 mice (Figure 4B), excluding major differences in the turnover of these receptors in the absence of GGA2. Moreover, plasma
levels of four different lysosomal acid hydrolases were assayed and
found to be similar between wt and Gga22/2 mice (not shown),
indicating that acid hydrolase sorting is normal in the absence of
GGA2.

Figure 3 Growth retardation of
Gga22/2 mice. (A) Picture of day 1
pups from a single litter of a Tigm
Gga2+/2 cross in the mixed genetic
background shows that the homozygous knockout has a markedly reduced body size. (B) The male
Gga22/2 mouse (left mouse) in the
mixed genetic background is much
smaller than its female wt littermate
at 6 wk of age but is otherwise healthy.
(C) Weights were obtained from week
1 to week 12 and plotted according to
gender and genotype. Results shown
are mean 6 SEM for each time point.
Males: wt, n = 7; Gga2+/2, n = 11;
Gga22/2, n = 6. Females: wt, n = 3;
Gga2+/2, n = 2; Gga22/2, n = 2. P
values for pairwise comparisons of
mean weights between wt and
Gga22/2 male mice are as follows:
P , 0.05, P , 0.005, and P ,
0.0005. NS, not signiﬁcant. Statistical
analysis was not performed with the
females due to the small sample size.

DISCUSSION
The data presented here extend and clarify our previous report
concerning the consequences of Gga2 gene-trap disruption (Govero
et al. 2012). We reported that the Byg Gga22/2 mice in both the
mixed and C57BL/6J genetic backgrounds exhibit early embryonic
lethality, whereas the Tigm Gga22/2 mice in the C57BL/6NJ background display neonatal lethality. The current experiments unequivocally demonstrate that the early embryonic lethality of the Byg
Gga22/2 mice is not due the absence of GGA2 because the Byg
Gga2 gene-trap allele is clearly hypomorphic. Because the Gga1
and Gga3 genes were also disrupted using the same vector as in the
Byg Gga2 strain and the corresponding gene-trap homozygotes are
complete knockouts (Govero et al. 2012), this result was unexpected.
However, similar phenomena have been reported for a number of
other trapped genes, including the iron regulatory protein (IRP)-1
and IRP-2 genes where the pre-mRNAs transcribed from identical
gene-trap cassettes are processed very differently within the two different gene contexts, with the IRP1 mRNA being undetectable while
the IRP2 mRNA was unchanged (Galy et al. 2004). In the case of the
Byg Gga2 gene-trap allele, this alternate splicing around the gene-trap
cassette in many instances gives rise to near-normal levels of GGA2,
showing that the early embryonic lethality is the consequence of another factor that has yet to be identiﬁed. Based on the ﬁnding with the
Tigm Gga22/2 mice, we conclude that GGA2 is important for viability of neonates but appears to be dispensable once the mice are past
3 wk of age. In this regard, the genetic background has a major impact
in terms of the tolerance to the loss of GGA2, with more than 95%
lethality occurring in the C57BL/6NJ background (Govero et al. 2012)
compared with 56% in the C57BL6/Ola129Sv mixed genetic background. This difference is not due to increased expression of GGA2
in the mixed background. A similar phenotype has been reported for
Nedd4-22/2 mice, in which the targeted homozygous nulls in the
C57BL/6J background exhibit almost complete neonatal lethality,
which was partially rescued by crossing into the same mixed genetic

background as our mice (Boase et al. 2011). In addition, a number of
other gene knockouts in mice have been shown to present considerable variation in the penetrance of lethality, depending on the genetic
background in which the knockouts were made (Doetschman 2009).
In our previous study, it was shown that single knockouts of Gga1
and Gga3 in the mixed genetic background are, for the most part,
phenotypically normal (Govero et al. 2012). In addition, we reported
that Gga12/2 mice in the C57BL/6J background are viable. We have
now backcrossed Gga32/2 mice into the C57BL/6J background as well
and have found no obvious difference between the two genetic backgrounds with either knockout strain, indicating that loss of GGA1 or
GGA3 is well-tolerated in both strains, in contrast to the loss of
GGA2. We have shown that even though brain expression of the three
GGAs was detected at all stages of development, GGA2 expression
was highest at embryonic day 9 (day E9) through the end of week 1,
and then declined substantially reaching the lowest level in the adult
mouse brain (Govero et al. 2012). Brain expression levels of GGA1
and GGA3, however, remained consistently high from day E9 through
the adult stage (Govero et al. 2012). These ﬁndings are in concordance
with some non-redundant and vital function(s) mediated by GGA2
early in the life of a mouse. This is not to imply that GGA1 and GGA3
together are completely dispensable for survival. Our previous study
demonstrated that GGA1/GGA3 double knockout mice show 58%
neonatal lethality in the mixed genetic background, similar to the
56% lethality due to loss of GGA2 in the same background. What
are the overlapping compared to distinct physiological roles served by
GGA1/GGA3 compared to GGA2? This is an important question that
warrants future investigation.
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Figure 4 Analysis of serum IGF-II and brain IGF-II receptor (CI-MPR)
levels. (A) Serum IGF-II levels of newborn mice were determined by
ELISA as described in Materials and Methods. The serum obtained
from each pup was sufﬁcient to perform the assay in duplicate. Results
are mean 6 SD, n = 16 per group. (B) Western blot analysis of brain
tissue from two wt and two Tigm Gga22/2 mice in the mixed background. Twenty-ﬁve mg protein extract for each sample was subjected
to SDS-PAGE and immunoblot analysis of CI-MPR, SorLA, and Sortilin.
GAPDH (5 mg of lysate) was included as a loading control. NS, not
signiﬁcant as determined by Student t test.
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